美股市场个股详情
TEVA 梯瓦制药
- 13.985
- -0.065-0.46%
收盘价 05/01 16:00 (美东)
- 13.990
- +0.005+0.04%
盘后 16:10 (美东)
158.40亿总市值-27970市盈率TTM
14.140最高价13.700最低价949.98万股成交量13.980今开14.050昨收1.32亿成交额0.84%换手率亏损市盈率(静)11.33亿总股本14.46552周最高2.11市净率157.45亿流通值7.08552周最低--股息TTM11.26亿流通股68.007历史最高--股息率TTM3.13%振幅3.107历史最低13.906平均价1股每手
梯瓦制药股票讨论区
登录发表评论
UPDATE May 1
MAYDAY!!!
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
加载中...
10
3
$梯瓦制药(TEVA.US$ & alvotechpr
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
3
1
$梯瓦制药(TEVA.US$ Pray Kwan Yin bless teva
The analyst from J.P. Morgan expressed that Teva has effectively addressed concerns about the investments required to develop these assets preserving margins through strategic partnerships.
Teva's divestment of its API division is in line with its strategy to focus on branded medicines and slim down its generic medicine business. This move will enable Teva to concentrate its capital on driving the Pivot to Growth strategy, mainly around its innovative and generics portfolio.
The P/S ratio for Teva Pharmaceutical Industries indicates expected limited growth, as mirrored in investors’ reduced payout. This viewpoint might endure unless revenue prospects improve.
1
WHY I AM BUYING RDHL....BUY HAND OVER FIST
$Redhill Biopharma(RDHL.US$
As we're all aware, TEVA stands out as one of the premier generic labs in Israel, with even Warren Buffett having previously held a significant stake in its shares. As we gradually divest from TEVA throughout our portfolio, RDHL emerges as a substantial opportunity to allocate current funds for potential future gains. Personally, I've been acquiring shares extensively, and in my view, RDHL appears to be a potential blockbuste...
As we're all aware, TEVA stands out as one of the premier generic labs in Israel, with even Warren Buffett having previously held a significant stake in its shares. As we gradually divest from TEVA throughout our portfolio, RDHL emerges as a substantial opportunity to allocate current funds for potential future gains. Personally, I've been acquiring shares extensively, and in my view, RDHL appears to be a potential blockbuste...
暂无评论
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
Mod Tan : thanks for sharing
TinkerB3ll : Thanks @iamiam for the extensive list wondering what’s your thoughts on MSOS?
iamiam楼主 TinkerB3ll: I would rather have the individual companies. MSOS is a Blackrock creation with lots of swaps and derivatives, they even have bonds
its not bad if you hold it. it's just not my thing. too many swaps and derivatives for my liking.